ParaPRO is offering Natroba (spinosad) topical suspension, 0.9% for the topical treatment of scabies infestations in adult and pediatric patients four years of age and older. \r\n\r\nThe product is an FDA-approved, targeted topical prescription therapy with multi-ectoparasitic indications. \r\n\r\n[Read more: ParaPro obtains FDA nod for new indication of Natroba]\r\n\r\nThe company noted that the medication is the only FDA-approved, targeted topical prescription therapy that meets the latest FDA criteria for effectiveness and safety in treating scabies infestations. \r\n\r\nNatroba is dosed as a single, full-body application. \r\n\r\nThe medication has been approved as a topical treatment of head lice infestations since 2011.